がん免疫療法におけるネオアンチゲンと腫瘍変異負荷の役割:進歩,メカニズム,見通し
Shengbo Sun1, Lanchun Liu1, Jingkang Zhang1
1Department of General Surgery, State Key Lab of Digestive Health, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Journal of hematology & oncology
|September 2, 2025
まとめ
ネオアンチゲンと腫瘍変異負荷 (TMB) は,がん免疫療法における重要なバイオマーカーである. 治療への反応を予測し ワクチンや免疫チェックポイント阻害剤 (ICI) などのパーソナライズされた治療法を指針として使用します
科学分野:
- 腫瘍学
- 免疫学
- ゲノミクス
背景:
- 癌の免疫療法では 腫瘍と戦うために 免疫系を利用します
- ネオアンチゲン (変異による腫瘍特異ペプチド) と腫瘍変異負荷 (TMB) は重要なバイオマーカーである.
- これらのバイオマーカーは パーソナライズされたがん治療の指針となります
研究 の 目的:
- 精密免疫腫瘍学における新抗原とTMBの役割を強調する.
- 免疫療法の有効性に対する予測的価値について議論する.
- 臨床実務への統合を模索する.
主な方法:
- 新抗原の予測のための高通量配列化,生物情報学,免疫ペプチドミクス.
- 変異負荷を評価するためのTMB定量化
- ネオアンチゲンベースの治療法とバイオマーカーとしてのTMBの臨床試験データの分析
主要な成果:
- MHC結合とT細胞認識の評価により,ネオアンチゲン予測の精度が向上しました.
- mRNAワクチンを含むネオアンチゲンベースの治療法は,免疫チェックポイント阻害剤 (ICI) との相乗効果を示しています.
- TMBは,ICI治療のための患者様を層分けるための承認されたバイオマーカーであり,液体生検および単細胞技術による効率的な測定です.
結論:
- ネオアンチゲンとTMBは 精密免疫腫瘍学の進歩に不可欠です
- これらのバイオマーカーは 治療効果を最大化し 耐性を克服し 持続的な癌寛解を促進します
- ネオアンチゲン療法と化学療法/放射線療法を併用すると,有効性が向上し,耐性を克服します.
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K


